4//SEC Filing
Hindman Andrew A. 4
Accession 0001179110-21-008394
CIK 0001583107other
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 6:55 PM ET
Size
4.8 KB
Accession
0001179110-21-008394
Insider Transaction Report
Form 4
Hindman Andrew A.
SVP, Chief Financial Officer
Transactions
- Tax Payment
Ordinary Shares
2021-08-20$14.05/sh−17,464$245,369→ 167,380 total
Footnotes (1)
- [F1]Shares withheld to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. The share withholding transaction was with the issuer and did not involve an open market transaction.
Documents
Issuer
Theravance Biopharma, Inc.
CIK 0001583107
Entity typeother
Related Parties
1- filerCIK 0001607965
Filing Metadata
- Form type
- 4
- Filed
- Aug 23, 8:00 PM ET
- Accepted
- Aug 24, 6:55 PM ET
- Size
- 4.8 KB